Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zaofeng Yang

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Nature Cancer|June 4, 2026
Bacterial engineering for cancer therapyNoah Chen, Zaofeng Yang, Nicholas Arpaia
Journal of Molecular Histology|June 20, 2018
Cell type specific expression of Follistatin-like 1 (Fstl1) in mouse embryonic lung developmentXue Liu, Yingying Liu, Zaofeng Yang, et al.
Biomaterials|April 2, 2021
Efficient intracellular delivery of p53 protein by engineered protein crystals restores tumor suppressing function in vivoZaofeng Yang, Marianne M M Lee, Michael K Chan
Journal of the American Chemical Society|May 15, 2020
<i>In Vivo</i> Enzyme Entrapment in a Protein CrystalBradley S Heater, Zaofeng Yang, Marianne M Lee, et al.
Journal for Immunotherapy of Cancer|September 14, 2022
Restoration of p53 activity via intracellular protein delivery sensitizes triple negative breast cancer to anti-PD-1 immunotherapyZaofeng Yang, Jacquelyne Ka-Li Sun, Marianne M Lee, et al.
Acta Biomaterialia|September 8, 2021
Cytosolic delivery of CDK4/6 inhibitor p16 protein using engineered protein crystals for cancer therapyZaofeng Yang, Meigui Yang, Hei-Man Chow, et al.
Iscience|May 29, 2020
Targeted Myoglobin Delivery as a Strategy for Enhancing the Sensitivity of Hypoxic Cancer Cells to RadiationZaofeng Yang, Bradley S Heater, Clayton T Cuddington, et al.
Biorxiv : the Preprint Server for Biology|February 12, 2026
Engineered probiotics for tumor-targeted combination chemoimmunotherapyZaofeng Yang, Jongwon Im, Noah Chen, et al.
ACS Applied Materials & Interfaces|September 6, 2024
A Targeted and Protease-Activated Genetically Encoded Melittin-Containing Particle for the Treatment of Cutaneous and Visceral LeishmaniasisMadiha Habib, Jiale Zheng, Chin-Fung Chan, et al.
Science Immunology|October 18, 2024
Programmable bacteria synergize with PD-1 blockade to overcome cancer cell-intrinsic immune resistance mechanismsFangda Li, Zaofeng Yang, Thomas M Savage, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Nature Cancer|June 4, 2026
Bacterial engineering for cancer therapyNoah Chen, Zaofeng Yang, Nicholas Arpaia
Journal of Molecular Histology|June 20, 2018
Cell type specific expression of Follistatin-like 1 (Fstl1) in mouse embryonic lung developmentXue Liu, Yingying Liu, Zaofeng Yang, et al.
Biomaterials|April 2, 2021
Efficient intracellular delivery of p53 protein by engineered protein crystals restores tumor suppressing function in vivoZaofeng Yang, Marianne M M Lee, Michael K Chan
Journal of the American Chemical Society|May 15, 2020
<i>In Vivo</i> Enzyme Entrapment in a Protein CrystalBradley S Heater, Zaofeng Yang, Marianne M Lee, et al.
Journal for Immunotherapy of Cancer|September 14, 2022
Restoration of p53 activity via intracellular protein delivery sensitizes triple negative breast cancer to anti-PD-1 immunotherapyZaofeng Yang, Jacquelyne Ka-Li Sun, Marianne M Lee, et al.
Acta Biomaterialia|September 8, 2021
Cytosolic delivery of CDK4/6 inhibitor p16 protein using engineered protein crystals for cancer therapyZaofeng Yang, Meigui Yang, Hei-Man Chow, et al.
Iscience|May 29, 2020
Targeted Myoglobin Delivery as a Strategy for Enhancing the Sensitivity of Hypoxic Cancer Cells to RadiationZaofeng Yang, Bradley S Heater, Clayton T Cuddington, et al.
Biorxiv : the Preprint Server for Biology|February 12, 2026
Engineered probiotics for tumor-targeted combination chemoimmunotherapyZaofeng Yang, Jongwon Im, Noah Chen, et al.
ACS Applied Materials & Interfaces|September 6, 2024
A Targeted and Protease-Activated Genetically Encoded Melittin-Containing Particle for the Treatment of Cutaneous and Visceral LeishmaniasisMadiha Habib, Jiale Zheng, Chin-Fung Chan, et al.
Science Immunology|October 18, 2024
Programmable bacteria synergize with PD-1 blockade to overcome cancer cell-intrinsic immune resistance mechanismsFangda Li, Zaofeng Yang, Thomas M Savage, et al.
Pageof 2